Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stocks, par value $0,0001 per share
-
Shares outstanding
-
58.5M
-
Number of holders
-
83
-
Total 13F shares, excl. options
-
24.9M
-
Shares change
-
-2.06M
-
Total reported value, excl. options
-
$85.5M
-
Value change
-
-$4.28M
-
Put/Call ratio
-
0.03
-
Number of buys
-
42
-
Number of sells
-
-43
-
Price
-
$3.44
Significant Holders of BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) as of Q1 2024
101 filings reported holding BCAB - BioAtla, Inc. - Common Stocks, par value $0,0001 per share as of Q1 2024.
BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) has 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.9M shares
of 58.5M outstanding shares and own 42.47% of the company stock.
Largest 10 shareholders include Soleus Capital Management, L.P. (4.07M shares), BlackRock Inc. (2.78M shares), VANGUARD GROUP INC (2.1M shares), MORGAN STANLEY (1.91M shares), TANG CAPITAL MANAGEMENT LLC (1.47M shares), DEUTSCHE BANK AG\ (1.24M shares), Cormorant Asset Management, LP (1.17M shares), RENAISSANCE TECHNOLOGIES LLC (996K shares), GEODE CAPITAL MANAGEMENT, LLC (923K shares), and MILLENNIUM MANAGEMENT LLC (874K shares).
This table shows the top 83 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.